Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine-Esketamine for Delirium in ICU
NCT06468436Not yet recruiting
- Sponsor
- Peking University First Hospital
- Start
- Nov 2025
- Primary completion
- Dec 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of esketamine in delirium (2 arms), sponsored by Peking University First Hospital. Primary endpoint: Incidence of delirium within 7 days. Planned start Nov 2025; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
delirium
Beyond the preview
Go deeper on NCT06468436.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06468436.